Furthermore, the known cancer-promoting effects of an enhanced GH/IGF1 axis (Junnila et al., 2013) could, to some extent, be compensated for by up-regulation of apoptosis and p53 signaling because these are the major mechanisms of cancer suppression (Bieging et al., 2014). Here, TP53 is linked to cancer.